The myriad partnerships Walgreens Boots Alliance has signed in recent years will be closely watched in 2020 amid speculation about the retail drugstore giant’s next big move.
Rumors have swirled that Walgreens may be taken private in a massive leveraged buyout involving private equity firms like KKR & Co., according to reports in the last two months. This is speculation Walgreens hasn’t confirmed nor publicly entertained as a strategy.
In the meantime, Walgreens observers are anxiously awaiting some financial results from the myriad partnerships that the retail pharmacy chain has formed with health insurers like Humana, medical care providers like VillageMD and UnitedHealth Group’s and Optum’s MedExpress urgent care unit and the Kroger grocery chain. Most of these efforts have been considered tests and have yet to be scaled nationally.
“We believe all these partnerships aim at increasing traffic to (Walgreens) stores and thus boost sales,” Mizuho Securities’ Ann Hynes said in a report last month, echoing her fellow analysts who regularly ask about the partnerships on earnings calls and investor meetings. “However, we view so far these partnerships have not yielded material financial benefits to (Walgreens) yet.”
In some of his most recent public comments, Walgreens CEO Stefano Pessina reiterated at the 2019 Forbes Healthcare Summit earlier this month in New York that partnerships remain the most cost-effective way for the global drugstore chain to remain competitive and grow in the future. “The partnership is the best and cheapest way to transform the industry you are working in,” Pessina told Forbes Chairman and Editor-in-Chief Steve Forbes in an interview at the summit.
Walgreens strategy contrasts with that of rival CVS Health, which a year ago spent almost $70 billion buying Aetna, the nation’s third largest health insurer.
CVS observers see Aetna’s more than 20 million health plan subscribers increasingly being guided to CVS drugstores for lower cost retail health services over Walgreens. CVS is enticing customers with lower cost personal care items and primary care services via its MinuteClinics and a new “HealthHub” format that will be in 1,500 stores by the end of 2021.
Should Walgreens entertain the idea of going private via leveraged buyout, there is concern new ownership could slow capital expenditures on the partnerships in favor of boosting profits and cash flow. Walgreens also has more than 9,200 stores and management already decided in recent months to raise its annual cost-cutting target to “at least $1.8 billion by fiscal 2022,” Walgreens global chief financial officer James Kehoe said two months ago.
Still, Walgreens will have to continue to pursue ways to bring in new customers and any new owner or management team won’t change plans to shift from a healthcare strategy.
“We’re strongly focused on creating neighborhood health destinations around a more modern pharmacy,” Alex Gourlay, Walgreens co-chief operating officer said in October. “We have made significant steps during the year to develop our primary care business.”
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.